SCHEMBL13898218

SCHEMBL13898218

NC(=O)C1(C(=O)NCCCNc2nc(Nc3cccc(NC(=O)N4CCCC4)c3)ncc2I)CC1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ULK1 O75385 3/20 0.74
▸ PDK1 Q15118 3/20 0.74
▸ ULK2 Q8IYT8 3/20 0.74
▸ TBK1 Q9UHD2 14/20 0.69
▸ PDPK1 O15530 6/20 0.69
▸ NUAK1 O60285 2/20 0.69
▸ IKBKE Q14164 1/20 0.69
▸ CGAS Q8N884 1/20 0.69
▸ CDK2 P24941 1/20 0.62
▸ STK17A Q9UEE5 3/20 0.59
▸ MARK3 P27448 3/20 0.59
▸ MARK4 Q96L34 3/20 0.59
▸ TYK2 P29597 3/20 0.51
▸ AAK1 Q2M2I8 2/20 0.51
▸ MKNK2 Q9HBH9 2/20 0.51
▸ STK17B O94768 1/20 0.51
▸ SIK2 Q9H0K1 1/20 0.51
▸ NTRK1 P04629 2/20 0.51
▸ BMPR2 Q13873 2/20 0.51
▸ STK16 O75716 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3863942 0.91 PDPK1 (0.76) ULK1PDK1ULK2TBK1PDPK1
SCHEMBL3867811 0.91 ULK1 (0.76) ULK1PDK1ULK2TBK1PDPK1
SCHEMBL3865565 0.89 PDPK1 (0.75) ULK1PDK1ULK2TBK1PDPK1
SCHEMBL29915250 0.89 PDPK1 (0.75) ULK1PDK1ULK2TBK1PDPK1
SCHEMBL3865033 0.82 PDPK1 (0.74) ULK1PDK1ULK2TBK1PDPK1
SCHEMBL3868849 0.82 PDPK1 (0.74) ULK1PDK1ULK2TBK1PDPK1
Bx-795 SCHEMBL3865995 0.81 TBK1 (1.00) ULK1PDK1ULK2TBK1PDPK1
Bx-795 SCHEMBL29850938 0.81 TBK1 (1.00) ULK1PDK1ULK2TBK1PDPK1
Bx-795 SCHEMBL29382898 0.81 TBK1 (1.00) ULK1PDK1ULK2TBK1PDPK1
Bx-795 SCHEMBL31695384 0.81 TBK1 (0.98) ULK1PDK1ULK2TBK1PDPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7504410-B2 Chk-, Pdk- and Akt-inhibitory pyrimidines, their production and use as pharmaceutical agents SCHERING AKTIENGESELLSCHAFT (DE) 2009-03-17 — — US disclosed
US-7504410-B2 Chk-, Pdk- and Akt-inhibitory pyrimidines, their production and use as pharmaceutical agents SCHERING AKTIENGESELLSCHAFT (DE) 2009-03-17 — — US disclosed
Send feedback